INTRODUCTION: To date, the resistance of infectious agents has been assessed by widely varying criteria in different countries. Therefore, published data on resistance often cannot be meaningfully compared. In Germany, different laboratories can potentially report different results for identical microorganisms, since there is no uniform system for categorization. This situation is unsatisfactory. METHODS: Selective literature review and evaluation of committee reports. RESULTS: The new ISO standard 20776 for determination of the resistance of infectious agents and the harmonized evaluation system of the European Society for Clinical Microbiology and Infectious Diseases provide a new basis for susceptibility testing. The categorization of infectious agents as "susceptible," "intermediate," or "resistant" to particular antibiotics will become more reliable and will be consistent throughout Europe. DISCUSSION: For a number of antibiotics, the criteria for evaluation of infectious agents as "susceptible," "intermediate", or "resistant" will change. Comparability with earlier resistance data will be compromised. However, the new evaluation criteria reflect current knowledge on the pharmacokinetics and pharmacodynamics of antimicrobial substances.
INTRODUCTION: To date, the resistance of infectious agents has been assessed by widely varying criteria in different countries. Therefore, published data on resistance often cannot be meaningfully compared. In Germany, different laboratories can potentially report different results for identical microorganisms, since there is no uniform system for categorization. This situation is unsatisfactory. METHODS: Selective literature review and evaluation of committee reports. RESULTS: The new ISO standard 20776 for determination of the resistance of infectious agents and the harmonized evaluation system of the European Society for Clinical Microbiology and Infectious Diseases provide a new basis for susceptibility testing. The categorization of infectious agents as "susceptible," "intermediate," or "resistant" to particular antibiotics will become more reliable and will be consistent throughout Europe. DISCUSSION: For a number of antibiotics, the criteria for evaluation of infectious agents as "susceptible," "intermediate", or "resistant" will change. Comparability with earlier resistance data will be compromised. However, the new evaluation criteria reflect current knowledge on the pharmacokinetics and pharmacodynamics of antimicrobial substances.
Authors: D L Paterson; W C Ko; A Von Gottberg; J M Casellas; L Mulazimoglu; K P Klugman; R A Bonomo; L B Rice; J G McCormack; V L Yu Journal: J Clin Microbiol Date: 2001-06 Impact factor: 5.948
Authors: James R Beardsley; John C Williamson; James W Johnson; Christopher A Ohl; Tobi B Karchmer; David L Bowton Journal: Chest Date: 2006-09 Impact factor: 9.410
Authors: Cornelius Remschmidt; Sandra Schneider; Elisabeth Meyer; Barbara Schroeren-Boersch; Petra Gastmeier; Frank Schwab Journal: Dtsch Arztebl Int Date: 2017-12-15 Impact factor: 5.594
Authors: Sabrina Wanninger; Manuela Donati; Antonietta Di Francesco; Michael Hässig; Karolin Hoffmann; Helena M B Seth-Smith; Hanna Marti; Nicole Borel Journal: PLoS One Date: 2016-11-28 Impact factor: 3.240
Authors: Christoph Zutz; Markus Bacher; Alexandra Parich; Bernhard Kluger; Agnieszka Gacek-Matthews; Rainer Schuhmacher; Martin Wagner; Kathrin Rychli; Joseph Strauss Journal: Front Microbiol Date: 2016-04-13 Impact factor: 5.640
Authors: Mohammed S Abdallah; Rune Philemon; Anaam Kadri; Ashley Al-Hinai; Aliasgher M Saajan; Joshua G Gidabayda; Gibson S Kibiki; Blandina T Mmbaga Journal: East Afr Health Res J Date: 2018-04-01